Granite Investment Partners, LLC Pfizer Inc Transaction History

Granite Investment Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $221,805 - $282,045	-6,627 Closed	0 $0
Q2 2020 Aug 03, 2020	SELL	$30.12 - $36.54 $163,973 - $198,923	-5,444 Reduced 45.1%	6,627 $217,000
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $65,061 - $92,958	-2,407 Reduced 16.63%	12,071 $394,000
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $100,511 - $112,851	-2,718 Reduced 15.81%	14,478 $627,000
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $15,637 - $17,180	-417 Reduced 2.37%	17,196 $730,000
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $16,041 - $18,289	417 Added 2.42%	17,613 $769,000
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $30,540 - $37,043	-886 Reduced 4.9%	17,196 $758,000
Q2 2018 Aug 06, 2018	SELL	$32.98 - $35.16 $78,030 - $83,188	-2,366 Reduced 11.57%	18,082 $656,000
Q4 2017 Feb 01, 2018	BUY	$33.26 - $35.29 $19,390 - $20,574	583 Added 2.93%	20,448 $741,000
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $615,815 - $678,389	19,865	19,865 $709,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Investment Partners, LLC with notifications on news.